$24.19
1.02% day before yesterday
Nasdaq, May 09, 10:01 pm CET
ISIN
US98419J2069
Symbol
XOMA
Sector
Industry

XOMA Corporation Stock price

$24.19
+4.00 19.81% 1M
-6.97 22.37% 6M
-2.09 7.95% YTD
+0.50 2.11% 1Y
+6.61 37.60% 3Y
-0.85 3.39% 5Y
-50.01 67.40% 10Y
Nasdaq, Closing price Fri, May 09 2025
-0.25 1.02%
ISIN
US98419J2069
Symbol
XOMA
Sector
Industry

Key metrics

Market capitalization $289.14m
Enterprise Value $301.88m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 10.60
P/S ratio (TTM) P/S ratio 10.15
P/B ratio (TTM) P/B ratio 3.53
Revenue growth (TTM) Revenue growth 498.72%
Revenue (TTM) Revenue $28.49m
EBIT (operating result TTM) EBIT $-39.98m
Free Cash Flow (TTM) Free Cash Flow $-14.51m
Cash position $106.51m
EPS (TTM) EPS $-2.06
P/E forward negative
P/S forward 8.78
EV/Sales forward 9.17
Short interest 1.83%
Show more

Is XOMA Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,793 stocks worldwide.

XOMA Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a XOMA Corporation forecast:

3x Buy
75%
1x Hold
25%

Analyst Opinions

4 Analysts have issued a XOMA Corporation forecast:

Buy
75%
Hold
25%

Financial data from XOMA Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
28 28
499% 499%
100%
- Direct Costs 0.22 0.22
78% 78%
1%
28 28
652% 652%
99%
- Selling and Administrative Expenses 65 65
166% 166%
229%
- Research and Development Expense 2.88 2.88
1,957% 1,957%
10%
-40 -40
90% 90%
-140%
- Depreciation and Amortization 0.22 0.22
78% 78%
1%
EBIT (Operating Income) EBIT -40 -40
83% 83%
-140%
Net Profit -14 -14
66% 66%
-49%

In millions USD.

Don't miss a Thing! We will send you all news about XOMA Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

XOMA Corporation Stock News

Neutral
GlobeNewsWire
4 days ago
EMERYVILLE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today its Chief Executive Officer, Owen Hughes, and Chief Investment Officer, Brad Sitko, will be featured speakers at the H.C. Wainwright 1st Annual Royalty Company Virtual Conference being held May 13, 2025.
Neutral
GlobeNewsWire
27 days ago
XOMA Royalty sold the remaining Kinnate pipeline assets for a total of up to $270 million in upfront and milestone payments, plus royalties on commercial sales at rates ranging from low single digits to mid-teens
Neutral
Accesswire
about one month ago
LUND, SWEDEN / ACCESS Newswire / April 8, 2025 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, today announces that it has earned a 1 million USD milestone payment, following Takeda's (TSE:4502/NYSE:TAK) initiation of Phase 3 clinical ...
More XOMA Corporation News

Company Profile

XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.

Head office United States
CEO Owen Hughes
Employees 13
Founded 1981
Website www.xoma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today